Cargando…

Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?

Recent clinical trials have shown several multi-target tyrosine kinase inhibitors (TKIs) to be effective in the treatment of osteosarcoma. However, these TKIs have a number of targets, and it is yet unclear which of these targets has a key role in osteosarcoma treatment. In this review, we first sum...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhichao, Niu, Xiaohui, Yao, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485562/
https://www.ncbi.nlm.nih.gov/pubmed/32984034
http://dx.doi.org/10.3389/fonc.2020.01642

Ejemplares similares